Susquehanna Portfolio Strategies’s Ionis Pharmaceuticals IONS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.21M	Hold	95,960	–	–	0.11%	239
2025 Q4	$7.59M	Hold	95,960	–	–	0.12%	232
2025 Q3	$6.28M	Buy	95,960 +3,060	+3%	+$149K	0.1%	268
2025 Q2	$3.67M	Buy	+92,900	New	+$3.04M	0.08%	268
2024 Q4	–	Sell	-10,894	Closed	-$436K	–	168
2024 Q3	$436K	Sell	10,894 -32,134	-75%	-$1.5M	0.03%	259
2024 Q2	$2.05M	Sell	43,028 -87,958	-67%	-$3.61M	0.08%	206
2024 Q1	$5.68M	Sell	130,986 -38,692	-23%	-$1.84M	0.13%	198
2023 Q4	$8.58M	Buy	+169,678	New	+$8.13M	0.15%	196

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna Portfolio Strategies's IONS Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 95,960 shares worth $7.21M. The position accounts for 0.11% of the portfolio, ranked #239.

Susquehanna Portfolio Strategies first reported a position in IONS in Q4 2023 and has held it in 8 quarters since. The position peaked at $8.58M in Q4 2023. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Susquehanna Portfolio Strategies held 95,960 shares of Ionis Pharmaceuticals worth $7.21M as of Q1 2026.
Susquehanna Portfolio Strategies left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
Ionis Pharmaceuticals made up 0.11% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #239 holding.
Susquehanna Portfolio Strategies first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
Susquehanna Portfolio Strategies's Ionis Pharmaceuticals position peaked at $8.58M in Q4 2023.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.